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Background: Aluminum overload can cause severe brain injury and neurodegeneration. Previous studies suggest
that prostacyclin synthase (PGIS) expression and prostacyclin receptor (IP) activation are beneficial for treatment of
acute traumatic and ischemic brain injury. However, the potential value of PGIS/IP signaling pathway to chronic
brain injury is still unclear. In this study, we investigated the change of PGIS/IP signaling pathway and the effect of
beraprost sodium (BPS) on chronic brain injury in chronic aluminum-overload rats.
Methods: Rat model of chronic cerebral injury was established by chronic intragastric administration of aluminum
gluconate(Al3+ 200 mg/kg per day,5d a week for 20 weeks). The methods of ELISA, qRT-PCR and Western blotting
were used to detect the PGI2 level and the PGIS and IP mRNA and protein levels in hippocampi of chronic
aluminum-overload rats, respectively. Rat hippocampal superoxide dismutase (SOD) activity and malondialdehyde
(MDA) content also were measured. The effects of BPS (6, 12 and 24 μg⋅kg-1) on brain injury in chronic
aluminum-overload rats were evaluated.
Results: Compared with the control group, PGIS mRNA expression, PGI2 level, and the IP mRNA and protein
expressions significantly increased in hippocampi of chronic aluminum-overload rats. Administration of BPS
significantly improved spatial learning and memory function impairment and hippocampal neuron injury induced
by chronic aluminum overload in rats. Meanwhile, administration of BPS resulted in a decrease of PGI2 level and
downregulation of PGIS and IP expressions in a dose-dependent manner. Aluminum overload also caused a
decrease of SOD activity and an increase of MDA content. Administration of BPS significantly blunted the decrease
of SOD activity and the increase of MDA content induced by aluminum overload in rats.
Conclusions: BPS has a significant neuroprotective effect on chronic brain injury induced by aluminum overload in
rats. Remodeling the balance of PGIS/IP signaling pathway and inhibition of oxidative stress involve in the
neuroprotective mechanism of BPS in aluminum-overload rats. The PGIS/IP signaling pathway is a potential
therapeutic strategy for chronic brain injury patients.
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Aluminum, which accounts for about 8% of the earth
crust mass, is the most widely distributed metal in air,
water and soil and is extensively used in modern daily life.
Therefore, we unavoidably take in aluminum by various
routes. However, the physiological action of aluminum to
humans is not clear. It is well known that aluminum over-
load can cause severe brain injury and neurodegeneration
since the aluminum toxicity to humans was first reported
at early 1970s. In particular, aluminum was detected in
senile plaques and neurofibrillary tangles in brain tissue
of Alzheimer’s disease (AD) patients, indicating that
aluminum neurotoxicity may be involved in the patho-
genesis of AD [1,2]. Despite some debated studies, the
majority of scholars think there is a close relationship
between aluminum exposure and the risk of developing
AD [3]. Aluminum could play a role in chronic brain
damage and neurodegeneration by enhancing oxidative
stress and inflammation [4]. However, the mechanism
of aluminum neurotoxicity is not well understood and
should be further clarified.
Proinflammatory cytokines including tumor necrosis
factor (TNF)-α, interleukins (ILs) and transforming growth
factor (TGF)-β make large contributions to the neuroin-
flammatory response in patients with chronic brain injury.
IL-1 and TNF-α can activate many cerebral signaling path-
ways including the arachidonic acid (AA) metabolic cas-
cade [5]. Under the action of cyclooxygenase (COX), AA
can be converted to bioactive prostaglandin (PG)H2.
PGH2 serves as the substrate for multiple specific prosta-
glandin synthases (PGS) and can be metabolized to PGD2,
PGE2, PGF2a, PGI2 or thromboxane (TX)A2. COX has at
least two isoforms, the constitutive COX-1 and the indu-
cible COX-2. COX-1 is prominently expressed in microglia
of human brain [6]. COX-2 is highly expressed in the neur-
onal cell bodies and dendritic regions of hippocampus,
cerebral cortex, and amygdale. COX-2 can be rapidly in-
duced following traumatic brain injury, acute cerebral is-
chemia, seizures, and neurodegeneration [7]. Our previous
studies also demonstrate that aluminum significantly in-
duced brain injury and COX-2 overexpression, and the
COX-2 inhibitor protected against chronic brain injury
in rats [8]. However, celecoxib and naproxen could
neither prevent AD nor improve cognitive function of
AD patients in some randomized trials [9,10]. A further
clinical trial shows that therapeutic effects of NSAIDs
differ at different stages and COX inhibitors have ser-
ious adverse effects at later stages of AD [11]. Despite
the failed clinical treatment trial and the terminated pre-
vention trial for NSAIDs, the specific COX downstream
signaling pathway has become a focus in neurological
research to observe its potential therapeutic values for
modification of chronic brain injury and for avoidance of
the toxicities of NSAIDs.Prostacyclin, also known as PGI2, is derived from
PGH2 under the action of prostacyclin synthase (PGIS).
Through acting mainly on the membrane-bound prosta-
cyclin receptor (IP), PGI2 and its analogues play lots of
physiological and pharmacological functions. Combined
gene transfer of COX-1 and PGIS could increase PGI2
level and decrease cerebral infarct volume in rats with is-
chemic reperfusion [12]. Administration of PGI2 signifi-
cantly reduced the cortical lesion of rats with traumatic
brain injury [13]. IP knockout mice developed more severe
cortical lesion than wild type mice [14].
These studies suggest that activation of IP is beneficial
for acute cerebral ischemic insult and traumatic brain
injury. However, the PGI2 level, and the mRNA and pro-
tein expressions of PGIS and IP in brains of rats with
chronic brain injury have not been characterized. More-
over, there is no report about the effect of PGIS/IP sig-
naling pathway activation on cerebral damage in rat with
chronic brain injury.
We previously established a rat model of chronic brain
injury via chronic intragastric administration of aluminum
gluconate. Administration of aluminum gluconate caused
an increase of hippocampal aluminum level (21.53 ± 2.90
vs 61.17 ± 9.25 μg/g) and learning and memory function
disorder [15,16]. The present study was designed to inves-
tigate the effects of beraprost sodium (BPS, an agonist of
IP) on chronic brain injury and to primary explore neu-
roprotective mechanism of BPS through detecting the
change of hippocampal neuronal PGI2 content, and the
expressions of PGIS and IP at mRNA and protein levels
in chronic aluminum-overload rats.
Methods
Reagents
RNAiso Plus total RNA extraction kit, and PrimeScipt
RT regeant Kit with gDNA Eraesr (Perfect Real Time)
(TAKARA Bio(Dalian) CO.,LTD, Dalian); iQ SYBR
Green Real-Time PCR Supermix (BioRad, USA); mouse
antirat β-actin monoclonal antibodies, and goat antimose
horseradish peroxidase secondary antibodies (Zhongshan
Goldbridge Technology Co., Ltd., Beijing); rabbit antirat
IP monoclonal antibodies, and goat antirabbit horseradish
peroxidase secondary antibodies (Cayman, USA); BCA
protein detection kit, and BeyoECL chemiluminescence
detection kit (Beyotime Institute Biotechnology, Shanghai)
were used. BPS (Beijing Tide Pharmaceutical CO.,LTD,
Beijing) was prepared with 0.5% sodium carboxy methyl
cellulose (CMC-Na) before use.
Animals and experimental protocol
A total of 75 male Sprague Dawley rats, weighing 200-
250 g and aged 8 weeks, were supplied from the Labora-
tory Animal Center of Chongqing Medical University (No.
SCXK (Yu) 2007-0001). They were housed in standard
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dark cycles (light from 8:00-20:00). All experimental pro-
cedures on animals were approved by Institutional Animal
Ethics Committee of Chongqing Medical University. The
research was also conducted in accordance with the guide
for the Care and Use of Laboratory Animals promulgated
by the United States National Institutes of Health. The 75
rats were randomly divided into five group depending on
body weight (each n = 15): a control group, an aluminum-
treated group (Al-overload group), and three BPS-treated
groups (6, 12, and 24 μg⋅kg-1 BPS, marked as BPS-6
group, BPS-12 group and BPS-24 group, respectively).
Rats in the Al-overload group received chronic intragas-
tric administration of aluminum gluconate (Al3+ 200 mg/
kg per day), followed by administration of 0.5% CMC-Na
2 h later. Aluminum was administrated 5 days per week
for 20 continuous weeks. Two hours later after aluminum
administration, rats in BPS-treated groups were intragas-
trically administered with BPS (6, 12, and 24 μg⋅kg-1). The
control group was treated with an equal volume of sodium
gluconate followed by an equal volume of 0.5% CMC-Na
2 h later [8,16].
Morris water maze test
On the next day after aluminum administration was
stopped, the rats in each group were subjected to spatial
learning and memory test using a DMS-2 Morris water
maze (Institute of Materia Medica, Chinese Academy of
Medical Sciences, Beijing, China) with a diameter of 1.5 m,
height of 0.5 m, water depth of 0.4 m and temperature of
23 ± 2°C. The rats were subjected to study how to navigate
the maze for four days. On the fifth day, spatial memory
was tested as previously reported study [17]. The rats in
each group received a probe trial in which the platform
was removed. The time for the rat to pass through the
place, where the platform was previously placed, was called
as the time for exploring platforms (exploring time).
Pathomorphological observation
Six days after aluminum administration was completed,
four rats from each group were selected for histopatho-
logical observation. According to a reported method
[17], the rats were intraperitoneally anesthetized with 4%
chloral hydrate (1 mL/100 g) and transcardially perfused
with 150 mL of 0.9% saline containing 375U heparin,
followed by 200 mL of 4.0% paraformaldehyde fixing so-
lution containing 0.1 M phosphate buffer solution (PBS,
pH 7.2). The cerebral tissue was isolated and made into
coronal sections of 4 μm thicknesses for hematoxylin
and eosin staining (H.E). Neuronal pathological change
in rat hippocampus was observed under light micros-
copy. Ten consecutive fields from the dorsal hippocam-
pal CA1 subfield of each section were selected, and then
intact neurons were counted by a microscope at 400×magnification and the extent of cell death was estimated.
Dead neuron is characterized by eosinophilic change in-
cluding nerve cell became a deep and red cell with nuclear
pyknosis and nucleoli disappear under light microscope.
Measurement of malondialdehyde (MDA) content and
superoxide dismutase (SOD) activity
Four rat brains from each group were removed six days
after aluminum administration was completed. Hippo-
campus was homogenized with saline by a weight-
volume ratio of 1:9. The homogenate was centrifuged
and the supernatant was collected for detection of SOD
activity and MDA content according to the manufac-
turer’s manual (Jiancheng Bioengineering Ltd, Nanjing,
China). Protein content was measured by biuret spec-
trophotometry method.
Detection of PGI2 level
Hippocampal homogenate from each group (n = 4) was
prepared with saline by a weight-volume ratio 1 : 9,
followed by centrifugation at 8000 g × 10 min under 4°C.
The supernatant was collected for detection of PGI2 level
according to the manual of the enzyme-linked immuno-
sorbent assay (ELISA) kit (Cayman, USA). Since PGI2 can
be easily metabolized, the level of 6-keto-prostaglandin
F1α (6-keto-PGF1α), a metabolite of PGI2, was detected.
In order to avoid the post-mortem production of prosta-
noids from oxylipids, the indomethacin, a nonselective
inhibitor of COX-1 and COX-2, was added according to
the manual of the ELISA kit.
Quantitative real-time polymerase chain reaction
(qRT-PCR) analysis of PGI2 and IP mRNA expressions
Rat brain hippocampi from each group (n = 4) were re-
moved for qRT-PCR analysis of PGI2 and IP following
the learning and memory function test.
RNA was isolated and prepared by using an RNAiso
Plus total RNA isolation kit (TAKARA). PrimeScipt RT
regeant Kit with gDNA Eraesr (TAKARA) was used for
cDNA synthesis. The total reaction volume for erase of
genome DNA was 10 μL, including 2 μl of 5 × DNA
Eraser Buffer, 1 μl of gDNA Eraser, and 1 μg of total
RNA with RNase-Free ddH2O. Condition for erase of
genome DNA was 42°C for 2 min, followed by 4°C for
10 min. The total reaction volume for RT was 20 μL,
including 4 μl of 5 × PrimeScript Buffer, 1 μl of Prime-
Script RT Enzyme Mix I, 1 μg of RT Primer Mix, and
10 μl of reaction liquid with RNase Free ddH2O. The
RT conditions were 37°C for 15 min, 85°C for 4 sec and
4°C for 10 min. The synthesized cDNA was the template
for the qRT-PCR performed on the CFX RT-PCR detec-
tion system (Bio-Rad). The following primer sequences
were used: forward 5’-GCTACCTGACCCTGTATGGA
GT-3’, reverse 5’-GTCTTTATCCCCCACTGACAAG-3’
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3’, reverse 5’-CTGCGTGAATCCTCTGATCGT-3’ for IP;
forward 5’-ACAGCAACAGGGTGGTGGAC-3’, reverse
5’-TTTGAGGGTGCACGAACTT-3’ for glyceraldehyde
phosphate dehydrogenase (GAPDH). The total reaction
volume for qRT-PCR was 20 μL, including 10 μl of iQ
SYBR Green RT-PCR Supermix (BioRad), 0.6 μl of
forward/reverse primers (10 μM), 2 μl of cDNA, and
7.4 μl of RNase-Free ddH2O. The qRT-PCR conditions
were 95°C for 3 min, 95°C for 10 sec and annealing
temperature 57.9°C for PGIS (62.3°C for IP and 63.5°C
for GAPDH) 15 sec, 40 cycles. Melting curves were ana-
lyzed to verify single species PCR product. Fluorescent
data were acquired at the 60°C. A template-free negative
control was set for all experiments. GAPDH was used as
an internal control for sample normalization. Relative
expressions of PGIS and IP mRNA were calculated as:
ΔΔCt = ΔCt (Al-treated group)-ΔCt (control group).Western blotting of IP protein expression
Hippocampus (50 mg) was added with 0.5 ml of tissue
lysate solution for protein extraction and centrifugation
at 12,000 × g for 10 min at 4°C, and the supernatant was
used for Western blotting. The hippocampal protein
content was detected with the bicinchoninic acid (BCA)
method according to the directions of the protein detec-
tion kit.
Then,10% separating gel and 5% stacking gel were pre-
pared for separation of proteins using sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Protein was transferred to a polyvinylidene difluoride
(PVDF) membrane. The membrane was blocked for
1.0 h using PBS containing 5% fat-free milk (weight/vol-
ume). The blot was incubated overnight at 4°C with pri-
mary antibodies at 1:300 for IP and at 1:1000 dilutions
for β-actin, and then was incubated for 2 h at 37°C with
a secondary antibody at 1:2000 for β-actin and IP. Im-
munoreactive bands of IP and β-actin were visualized
with a BeyoECL plus chemiluminescence detection kit,
and the optical density of bands was detected by a
BioRad gel imaging and analysis system. The protein
level of IP was calculated as ratios of the corresponding
β-actin protein level.Statistical analysis
Data were presented as means ± standard deviation (SD)
and analyzed on SPSS 17.0. Between-group differences
in behavior test were evaluated by two-way analysis of
variance (ANOVA), and other between-group differ-
ences were evaluated by one-way ANOVA; the Al-
treated group and the control group were compared by
Dunnett’s t-test. Results were considered significant
with P < 0.05.Results
Spatial learning and memory function of rats
Throughout the 20 weeks of experiments, a total of nine
rats died, including two rats in control group, three rats
in Al-overload group, two rats in BPS-6 group and two
rats in BPS-12 group. However, autopsy results of dead
rats showed no obvious abnormality in peripheral tissues
or organs.
Compared to the control group, at the stage of spatial
learning function test from d 3 to d 4, the time for the
Al-overload group to learn to navigate the maze signifi-
cantly increased (p < 0.05); on d 5 at the stage of spatial
memory function test, the exploring time was signifi-
cantly longer, p < 0.01. Administration of BPS signifi-
cantly reduced the exploring time of aluminum-overload
rats (Table 1).
Morphological change of rat hippocampus
Hippocampal nerve cells in the control group were
closely arranged and well structured, and the morpho-
logical structure kept intact and clear. The hippocampal
CA1 subfield neurons in Al-overload group showed sig-
nificant karyopyknosis and loss. The administration of
BPS significantly prevented the histopathological changes
of hippocampal neurons caused by aluminum overload in
rats (Figure 1).
SOD activity and MDA content in rat hippocampus
MDA content increased and SOD activity decreased both
significantly in Al-overload rats compared to the control
group. BPS administration significantly blunted the in-
crease of MDA content and the decrease of SOD activity
induced by aluminum (Table 2).
Level of 6-k-PGF1α in rat hippocampus
The 6-k-PGF1α level in the hippocampus significantly
increased in the Al-overload rats. Treatment of BPS sig-
nificantly blunted the effect of aluminum on 6-k-PGF1α
level in hippocampus (Table 3).
Expression of PGIS mRNA in rat hippocampus
The qRT-PCR analysis showed that aluminum over-
load significantly increased PGIS mRNA expression in
rat hippocampus. The BPS significantly attenuated the
aluminum-induced increase of PGIS mRNA expression in
rat hippocampus (Table 4).
Expressions of IP mRNA and protein in rat hippocampus
Compared to the control group, hippocampal IP mRNA
level in aluminum-treated group significantly increased.
Administration of BPS significantly down regulated the
IP mRNA expression in Al-overload rat hippocampus
(Table 5).
Table 1 Effects of BPS on change of spatial learning and memory functions in aluminum overload rats
N Exploring time(s)
d 1 d 2 d 3 d 4 d 5
Control group 13 60.5 ± 17.4 40.1 ± 10.8 25.0 ± 11.3 19.7 ± 11.9 11.1 ± 6.5
Al-overload group 12 62.5 ± 15.7 49.1 ± 12.7 41.7 ± 19.1# 33.0 ± 11.8# 30.4 ± 17.7##
BPS-6 group 13 61.8 ± 15.5 39.6 ± 18.8 35.0 ± 16.6 27.4 ± 4.5 17.6 ± 8.5*
BPS-12 group 13 59.8 ± 18.3 36.3 ± 13.9 25.4 ± 6.9 21.1 ± 8.2* 14.3 ± 6.4**
BPS-24 group 15 62.6 ± 15.8 39.3 ± 13.2 31.4 ± 11.9 23.8 ± 9.9* 15.4 ± 8.7*
Data are expressed as mean ± SD of individual experiments. #P < 0.05 and ##P < 0.01 compared with control group; *P < 0.05 and **P < 0.01 compared with
Al-overload group.
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in the hippocampus was significantly higher in aluminum-
treated rats compared with the control group. Treatment
with BPS significantly reduced the aluminum-induced in-
crease of the IP protein expression in rats (Figure 2).Figure 1 Morphological change of rat hippocampal CA1 subfield neu
bars = 50 μm. Arrow indicates karyopyknosis of cells. Dead nerve cell is cha
deep and red cell with nuclear pyknosis and nucleoli disappear under light
**P < 0.01 compared with Al-overload group (mean ± SD, n = 4).Discussion
Episodic memory is a type of long-term memory based on
personal daily events and factual knowledge, which is the
most clinically relevant memory system. Episodic memory
depends on the limbic system, hippocampus and frontalron induced by aluminum overload. HE staining, 400×. Scale
racterized by eosinophilic change including nerve cell became a
microscope. ##P < 0.01 compared with control group; *P < 0.05 and
Table 2 Effects of BPS on change of MDA content and
SOD activity induced by aluminum overload in rat
hippocampus (n = 4)
MDA(nmol/mg protein) SOD(U/mg protein)
Control group 0.92 ± 0.09 13.54 ± 2.02
Al-overload group 4.45 ± 1.02## 7.98 ± 1.29##
BPS-6 group 2.92 ± 0.23* 9.01 ± 2.55
BPS-12 group 2.75 ± 0.49* 11.31 ± 1.20*
BPS-24 group 2.36 ± 0.70* 11.09 ± 0.90**
Data are expressed as mean ± SD of four individual experiments. ##P < 0.01
compared with control group; *P < 0.05 and **P < 0.01 compared with
Al-overload group (n = 4).
Table 4 Effects of BPS on change of PGIS mRNA expression
induced by aluminum overload in rat hippocampus (n = 4)
The relative mRNA expression (PGIS/GADPH)
Control group 1.00 ± 0.10
Al-overload group 5.05 ± 0.21##
BPS-6 group 3.27 ± 0.54*
BPS-12 group 2.42 ± 0.25**
BPS-24 group 1.97 ± 0.11**
Data are expressed as mean ± SD of four individual experiments. ##P < 0.01
compared with control group; *P < 0.05 and **P < 0.01 compared with
Al-overload group (n = 4).
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rons will result in cognitive impairment, which is the most
common hallmark for brain injury and neurodegeneration
[18]. Therefore, in this study, we observed the change of
histopathology in chronic aluminium gluconate-overload
rat hippocampi. The present study results showed that
chronic administration of aluminium gluconate resulted
in the impairment of spatial learning function and spatial
memory function and hippocampal neuron injury in rats.
This is similar with our previous reported results [8,15].
Prostacyclin synthase (PGIS) converts the PGH2 de-
rived from arachidonic acid via COX to PGI2 and pro-
duces important physiological function by acting mainly
on IP. Besides endothelial cells, PGIS is also predomin-
antly expressed in cortex and hippocampus neurons
companied with IP expression. Cerebral ischemia reper-
fusion injury will result in a delayed and transient induc-
tion of PGIS in cortex and hippocampus neurons [19].
COX-1/PGIS adenoviral gene transfer to substantia nigra
can prevent 6-OHDA-induced dopamine depletion and
behavioral deficits in rats [20]. Combined gene transfer
of COX-1 and PGIS also can increase PGI2 level and re-
duce cerebral infarct volume [12]. IP-/-mice compared
with wide type mice show significantly larger infarct vol-
ume and greater behavioral damage, and administration
of beraprost can significantly improve the neurological
deficits and decrease the infarct volume in wild type miceTable 3 Effects of BPS on change of 6-k-PGF1α content
induced by aluminum overload in rat hippocampus (n = 4)
6-k-PGF1α(ng/g tissue)
Control group 6.70 ± 1.28
Al-overload group 12.16 ± 1.35##
BPS-6 group 6.99 ± 0.50**
BPS-12 group 7.82 ± 0.31*
BPS-24 group 7.38 ± 1.08*
Data are expressed as mean ± SD of four individual experiments. ##P < 0.01
compared with control group; *P < 0.05 and **P < 0.01 compared with
Al-overload group (n = 4).[21]. These previous studies indicate that activation of
PGIS/IP signaling is neuroprotective for acute traumatic
brain injury and cerebral ischemic reperfusion insult.
However, potential value of such activation for chronic
brain injury is still not clear. We are the first to find that
compared with the control group, PGIS mRNA expres-
sion, PGI2 level and the IP mRNA and protein expres-
sions significantly increased in hippocampus of chronic
aluminum-overload rats. Our results suggest that there is
activation of PGIS/IP signaling pathway in chronic brain
injury rat hippocampus subjected to aluminum overload.
However, our studies showed that although the expression
levels of IP in the hippocampus were significantly induced,
the rats still displayed obvious spatial learning and
memory impairment and obvious hippocampal neurons
injury. These observations may be due to the increase of
IP levels being insufficient to antagonize the injury caused
by aluminum overload. Therefore, exogenous IP agonists
should be supplied.
Our experiments also showed that the administration
of BPS, which is an agonist of IP, could significantly im-
prove spatial learning and memory function impairment
and hippocampal neuron injury in chronic aluminum
overload rats. Meanwhile, the administration of BPS re-
sulted in a decrease of PGI2 level and a downregulation
of PGIS and IP expressions. Our results suggest that
BPS has a protective effect on cerebral injury induced byTable 5 Effects of BPS on change of IP mRNA expression
induced by aluminum overload in rat hippocampus
(n = 4)
The relative mRNA expression (IP/GADPH)
Control group 1.00 ± 0.10
Al-overload group 2.21 ± 0.22##
BPS-6 group 1.90 ± 0.02*
BPS-12 group 1.58 ± 0.05**
BPS-24 group 1.36 ± 0.11**
Data are expressed as mean ± SD of four individual experiments. ##P < 0.01
compared with control group; *P < 0.05 and **P < 0.01 compared with
Al-overload group (n = 4).
Figure 2 Effects of BPS on change of IP protein expression induced by aluminum overload in rat hippocampus (n = 4). The relative
protein level of IP was normalized to endogenous β-actin protein for each sample. Data are expressed as mean ± SD of four individual
experiments. #P < 0.05 compared with control group; *P < 0.05 compared with Al-overload group.
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ism can supply energy to neurons. At the same time, this
process may produce a lot of reactive compounds such
as oxyradicals and hydrogen peroxide, which may cause
peroxidation of biomembrane lipids, DNA damage, and
neuronal death. The present study results showed that
aluminum gluconate overload resulted in a significant
decrease of SOD activity and a significant increase of
MDA content. Our results further confirmed that oxida-
tive stress contributed to aluminum gluconate induced
chronic brain injury. Our previous studies showed that
chronic aluminium gluconate exposure caused significant
increase of Al, Fe, Mn, Cu and Zn level in rat hippocam-
pus [9]. The brain accumulation of these metals (Al, Fe,
Mn, Cu and Zn) could cause a significant oxidative stress.
The latter cause the tissue damage and formation of AA
by degradation of cell membrane phospholipids. BPS
administration also significantly blunted the decrease of
SOD activity and the increase of MDA content induced
by aluminum overload in rats.
About the neuroprotective mechanisms of BPS, consid-
ering it can relieve oxidative stress in aluminum-overload
rat, the effect of BPS on lipid peroxide formation may
involve in the neuroprotective mechanisms. Previous re-
search reported that BPS could relieve the ischemic and
recirculation-induced cerebral injury through inhibition of
lipid peroxide formation [22]. Besides this, BPS can relieve
oxidative stress injury and inhibit the neuroinflammation
in CNS by stimulating the IP receptor and in turn results
in decrease of cell membrane phospholipids degradation
and PGH2 formation. The decrease of PGH2 level might
cause the decrease of PGIS expression and PGI2 content.
On the other hand, a long-term use of BPS also causeddownregulation of IP mRNA and protein expressions by a
negative feedback regulation mechanism of receptor.
Together with these results, our experimental results
suggest that the PGIS/IP signaling pathway in chronic
brain injury rat hippocampus is activated and that bera-
prost sodium has a neuroprotective effect on chronic
brain injury through remodeling the balance of PGIS/IP
signaling pathway and inhibition of oxidative stress in
aluminum-overload rats. The PGIS/IP signaling pathway
is promising to potential therapeutic strategy for chronic
brain injury patients. However,the effect of BSP on IP
downstream signaling pathway is necessary to further
study in detail.Abbreviations
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